Clinical Trial Update: FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating the combination of FOLFIRINOX with IPI-926 in adults with advanced pancreatic adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX
• IPI-926 (IPI-926)

Snippet

Sponsor: Andrew Ko | Conditions: Pancreatic Cancer, Adenocarcinoma | Phase 1 | Status: COMPLETED